These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 8096759)
1. An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma. Rosen G Cancer Treat Res; 1993; 62():49-54. PubMed ID: 8096759 [No Abstract] [Full Text] [Related]
3. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan. Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444 [TBL] [Abstract][Full Text] [Related]
5. A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery. Delepine N; Delepine G; Desbois JC Cancer Treat Res; 1993; 62():327-32. PubMed ID: 7682092 [No Abstract] [Full Text] [Related]
6. Treatment of large osteosarcoma in children: new approach. Kobys VL; Konovalenko VF; Repinа NV; Golovko TS; Gulak LO; Tarasova TO; Zaharycheva EV; Matyushok OF Exp Oncol; 2013 Jun; 35(2):105-8. PubMed ID: 23828385 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results. Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534 [TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery. Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Göeken LN; Molenaar WM Cancer Treat Res; 1993; 62():361-4. PubMed ID: 7682095 [No Abstract] [Full Text] [Related]
9. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma. Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605 [TBL] [Abstract][Full Text] [Related]
10. The multi-institutional osteosarcoma study: an update. Link MP Cancer Treat Res; 1993; 62():261-7. PubMed ID: 7682087 [No Abstract] [Full Text] [Related]
11. An update of Scandinavian studies of osteosarcoma. Elomaa I Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745 [No Abstract] [Full Text] [Related]
12. Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990. Pratt CB; Meyer WH; Rao BN; Parham DM; Fleming ID Cancer Treat Res; 1993; 62():323-6. PubMed ID: 8096746 [No Abstract] [Full Text] [Related]
13. Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. Ferguson WS; Harris MB; Goorin AM; Gebhardt MC; Link MP; Shochat SJ; Siegal GP; Devidas M; Grier HE J Pediatr Hematol Oncol; 2001; 23(6):340-8. PubMed ID: 11563767 [TBL] [Abstract][Full Text] [Related]
14. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid. Cohen IJ Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026 [TBL] [Abstract][Full Text] [Related]
15. [Value of ifosfamide in neoadjuvant therapy for osteosarcoma]. Orthopade; 2013 Dec; 42(12):1072. PubMed ID: 24482827 [No Abstract] [Full Text] [Related]
16. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Winkler K; Bielack S; Delling G; Salzer-Kuntschik M; Kotz R; Greenshaw C; Jürgens H; Ritter J; Kusnierz-Glaz C; Erttmann R Cancer; 1990 Oct; 66(8):1703-10. PubMed ID: 2208024 [TBL] [Abstract][Full Text] [Related]
17. [Goal and results of the COSS study]. Flege S; Bielack S Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):282-8. PubMed ID: 15503258 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute. Kalifa C; Razafindrakoto H; Vassal G; Contesso G; Vanel D; Edeline V; Valteau D; Lemerle J Cancer Treat Res; 1993; 62():347-9. PubMed ID: 7682093 [No Abstract] [Full Text] [Related]
19. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Lin J; Leung WT; Ho SK; Ho KC; Kumta SM; Metreweli C; Johnson PJ Eur J Nucl Med; 1995 Jun; 22(6):553-5. PubMed ID: 7556302 [TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies. Miser JS; Pritchard DJ; Rock MG; Shives TC; Gilchrist GS; Smithson WA; Arndt CA; Edmonson JH; Schaid DJ Cancer Treat Res; 1993; 62():333-8. PubMed ID: 8096748 [No Abstract] [Full Text] [Related] [Next] [New Search]